Scarica l'app Stockscreener
9.09
4.48%
0.39
Precedente Chiudi:
$8.70
Aprire:
$8.61
Volume 24 ore:
225.09K
Relative Volume:
0.82
Capitalizzazione di mercato:
$500.75M
Reddito:
$79.55M
Utile/perdita netta:
$-37.25M
Rapporto P/E:
-12.89
EPS:
-0.7054
Flusso di cassa netto:
$-25.40M
1 W Prestazione:
+9.78%
1M Prestazione:
+6.94%
6M Prestazione:
+110.42%
1 anno Prestazione:
+74.47%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$8.09
$9.10
Portata 52W:
$3.378
$9.7126
Sight Sciences Inc Stock (SGHT) Company Profile
Nome
Sight Sciences Inc
Settore
Industria
Telefono
(415) 889-0550
Indirizzo
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
9.09 | 500.75M | 79.55M | -37.25M | -25.40M | -0.7054 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-10-15 | Iniziato | H.C. Wainwright | Buy |
| 2026-07-28 | Ripresa | UBS | Buy |
| 2026-01-05 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-08-08 | Aggiornamento | Lake Street | Hold → Buy |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-11-04 | Downgrade | Lake Street | Buy → Hold |
| 2024-08-21 | Iniziato | Lake Street | Buy |
| 2023-09-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2023-01-06 | Aggiornamento | Stifel | Hold → Buy |
| 2022-10-04 | Iniziato | Needham | Hold |
| 2022-07-26 | Iniziato | Stifel | Hold |
| 2022-02-03 | Iniziato | William Blair | Outperform |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Sight Sciences Inc Borsa (SGHT) Ultime notizie
Form 144 Sight Sciences For: 18 October By Investing.com - Investing.com South Africa
Form 4 Sight Sciences Inc For: 12 October By Investing.com - Investing.com Nigeria
Sight Sciences COO Alison Bauerlein sells $223,626 in stock By Investing.com - Investing.com South Africa
Sight sciences CFO Rodberg sells $63,812 in shares By Investing.com - Investing.com Nigeria
Sight Sciences CEO Paul Badawi sells $268,329 in stock By Investing.com - Investing.com Nigeria
Sight Sciences COO Alison Bauerlein sells $223,626 in stock - Investing.com
Sight Sciences COO Alison Bauerlein sells $223,626 in stock By Investing.com - Investing.com India
Sight Sciences director and CTO David Badawi sells $70,555 in stock - Investing.com Nigeria
Sight sciences CFO Rodberg sells $63,812 in shares By Investing.com - Investing.com India
Sight Sciences director and CTO David Badawi sells $70,555 in stock By Investing.com - Investing.com South Africa
Sight Sciences CEO Paul Badawi sells $268,329 in stock By Investing.com - Investing.com South Africa
Sight Sciences director and CTO David Badawi sells $70,555 in stock - Investing.com Canada
Sight Sciences director and CTO David Badawi sells $70,555 in stock - Investing.com UK
Form 4 Sight Sciences Inc For: 12 October By Investing.com - Investing.com Canada
Sight Sciences CEO Paul Badawi sells $268,329 in stock By Investing.com - Investing.com Canada
Sight Sciences director and CTO David Badawi sells $70,555 in stock - Investing.com
Sight Sciences CEO Paul Badawi sells $268,329 in stock - Investing.com
Sight sciences CFO Rodberg sells $63,812 in shares - Investing.com
Sight Sciences COO Alison Bauerlein sells $223,626 in stock By Investing.com - Investing.com Nigeria
EyeWorld Weekly, October 9, 2026 - EyeWorld
Have Sight Sciences Insiders Been Selling Stock? - Simply Wall Street
To cover stock-vesting taxes, Sight Sciences (SGHT) CFO sells 7,208 shares under a trading plan. - Stock Titan
To cover stock-vesting taxes, Sight Sciences (SGHT) CTO sells 7,797 shares under a trading plan. - Stock Titan
Under a trading plan, Sight Sciences (SGHT) CEO sells 29,653 shares to cover stock-vesting taxes. - Stock Titan
An officer's proposed $224K share sale at Sight Sciences (SGHT) includes coverage for an equity-award tax bill. - Stock Titan
An officer proposes selling 2,988 Sight Sciences (SGHT) shares, including shares to cover a tax obligation. - Stock Titan
A proposed $63.8K share sale at Sight Sciences (SGHT) includes shares to cover vested-award taxes. - Stock Titan
SpyGlass Pharma Acquires Advanced Vision Science, Securing Commercial IOL Supply, Accelerating Lens Portfolio Expansion - VisionMonday.com
Sight Sciences, Inc. (SGHT) Stock Price, News, Quote & History - Yahoo! Finance Canada
A proposed $268K share sale at Sight Sciences (SGHT) includes an amount to cover an equity-award tax bill. - Stock Titan
A former officer proposes selling 2,746 Sight Sciences (NASDAQ: SGHT) shares worth $24.8K. - Stock Titan
Sight Sciences launches OMNI Ultra surgical system for glaucoma By Investing.com - Investing.com Nigeria
SpyGlass Pharma Acquires Advanced Vision Science, Inc. - GlobeNewswire
Form 13D/A Kodiak Sciences Inc. For: 1 October By Investing.com - Investing.com Canada
Form 144 Sight Sciences For: 30 September By Investing.com - Investing.com Nigeria
Form 144 Sight Sciences For: 30 September By Investing.com - Investing.com Canada
Form 144 Sight Sciences For: 30 September By Investing.com - Investing.com UK
Baker Bros. Advisors Reports Multiple Open-Market Buys of Kodiak Sciences Stock - Kalkine Media
Former officer Jeremy Hayden proposes selling 22,254 Sight Sciences (SGHT) shares. - Stock Titan
Layoff Tracker: Merck adds 53 jobs to New Jersey chopping block - BioSpace
Sight Sciences at Morgan Stanley conference: growth returns across two platforms - Investing.com UK
SGHTSight Sciences Inc Volatility & Greeks - Finviz
Sight Sciences stock holds steady as investors watch recent ophthalmology results - AD HOC NEWS
Former Sight Sciences (SGHT) officer lines up more stock sales - Stock Titan
Sight Sciences stock holds steady as investors watch growth metrics - ad-hoc-news.de
Morgan Stanley healthcare talk featuring Sight Sciences will stream live Sept. 15 - Stock Titan
Former Sight Sciences (NASDAQ: SGHT) officer lines up more share sales after a string of summer trades - Stock Titan
Four new hires get rights to buy 269,000 Zentalis shares - Stock Titan
Price to sales forward of Sight Sciences, Inc. – NASDAQ:SGHT - TradingView
FDA Broadens ‘Indications for Use’ for Sight Sciences’ TearCare System - VisionMonday.com
Sight Sciences Inc Azioni (SGHT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sight Sciences Inc Azioni (SGHT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bauerlein Alison | Chief Operating Officer |
Oct 02 '26 |
Sale |
8.85 |
25,260 |
223,627 |
639,449 |
| Bauerlein Alison | Officer |
Oct 02 '26 |
Proposed Sale |
8.85 |
25,260 |
223,632 |
0 |
| Rodberg James | Officer |
Oct 02 '26 |
Proposed Sale |
8.85 |
7,208 |
63,814 |
0 |
| Taylor Brenton | Officer |
Oct 02 '26 |
Proposed Sale |
8.85 |
2,988 |
26,453 |
0 |
| Rodberg James | Chief Financial Officer |
Oct 02 '26 |
Sale |
8.85 |
7,208 |
63,812 |
216,829 |
| Badawi Paul | Officer |
Oct 01 '26 |
Proposed Sale |
9.05 |
29,653 |
268,333 |
0 |
| HAYDEN JEREMY B. | Former Officer |
Oct 01 '26 |
Proposed Sale |
9.02 |
2,746 |
24,769 |
0 |
| Badawi Paul | President and CEO |
Oct 01 '26 |
Sale |
9.05 |
29,653 |
268,330 |
6,092,819 |
| Badawi David | Officer |
Oct 01 '26 |
Proposed Sale |
9.05 |
7,797 |
70,556 |
0 |
| Badawi David | Chief Technology Officer |
Oct 01 '26 |
Sale |
9.05 |
7,797 |
70,555 |
1,975,075 |
0.34%
1.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):